WHITEHAWK THERAPEUTICS INC (WHWK) Fundamental Analysis & Valuation

NASDAQ:WHWK • US00032Q1040

Current stock price

3.51 USD
-0.03 (-0.85%)
At close:
3.45 USD
-0.06 (-1.71%)
After Hours:

This WHWK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. WHWK Profitability Analysis

1.1 Basic Checks

  • In the past year WHWK has reported negative net income.
  • WHWK had a negative operating cash flow in the past year.
  • WHWK had negative earnings in each of the past 5 years.
  • WHWK had a negative operating cash flow in each of the past 5 years.
WHWK Yearly Net Income VS EBIT VS OCF VS FCFWHWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • WHWK has a Return On Assets of -13.66%. This is amongst the best in the industry. WHWK outperforms 80.08% of its industry peers.
  • WHWK has a Return On Equity of -15.11%. This is amongst the best in the industry. WHWK outperforms 84.53% of its industry peers.
Industry RankSector Rank
ROA -13.66%
ROE -15.11%
ROIC N/A
ROA(3y)-51.3%
ROA(5y)-51.29%
ROE(3y)-66.33%
ROE(5y)-63.58%
ROIC(3y)N/A
ROIC(5y)N/A
WHWK Yearly ROA, ROE, ROICWHWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K

1.3 Margins

  • WHWK has a better Gross Margin (89.36%) than 91.10% of its industry peers.
  • WHWK's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WHWK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5YN/A
WHWK Yearly Profit, Operating, Gross MarginsWHWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. WHWK Health Analysis

2.1 Basic Checks

  • WHWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WHWK has been increased compared to 1 year ago.
  • The number of shares outstanding for WHWK has been increased compared to 5 years ago.
  • There is no outstanding debt for WHWK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WHWK Yearly Shares OutstandingWHWK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
WHWK Yearly Total Debt VS Total AssetsWHWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • WHWK has an Altman-Z score of 2.18. This is not the best score and indicates that WHWK is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of WHWK (2.18) is better than 65.57% of its industry peers.
  • There is no outstanding debt for WHWK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACCN/A
WACC9.2%
WHWK Yearly LT Debt VS Equity VS FCFWHWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • WHWK has a Current Ratio of 10.26. This indicates that WHWK is financially healthy and has no problem in meeting its short term obligations.
  • WHWK has a better Current ratio (10.26) than 80.85% of its industry peers.
  • WHWK has a Quick Ratio of 10.26. This indicates that WHWK is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of WHWK (10.26) is better than 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 10.26
Quick Ratio 10.26
WHWK Yearly Current Assets VS Current LiabilitesWHWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. WHWK Growth Analysis

3.1 Past

  • WHWK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.38%, which is quite impressive.
  • The Revenue for WHWK has decreased by -72.50% in the past year. This is quite bad
  • The Revenue for WHWK have been decreasing by -13.79% on average. This is quite bad
EPS 1Y (TTM)26.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.25%
Revenue 1Y (TTM)-72.5%
Revenue growth 3Y-22.28%
Revenue growth 5Y-13.79%
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.19% on average over the next years. This is quite good.
  • The Revenue is expected to decrease by -14.87% on average over the next years. This is quite bad
EPS Next Y24.89%
EPS Next 2Y12.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
WHWK Yearly Revenue VS EstimatesWHWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2021 2022 2023 2024 2025 2031 2032 2033 20M 40M 60M 80M 100M
WHWK Yearly EPS VS EstimatesWHWK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. WHWK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WHWK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WHWK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WHWK Price Earnings VS Forward Price EarningsWHWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WHWK Per share dataWHWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as WHWK's earnings are expected to grow with 12.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.19%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WHWK Dividend Analysis

5.1 Amount

  • WHWK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WHWK Fundamentals: All Metrics, Ratios and Statistics

WHITEHAWK THERAPEUTICS INC

NASDAQ:WHWK (4/2/2026, 8:01:25 PM)

After market: 3.45 -0.06 (-1.71%)

3.51

-0.03 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)05-06
Inst Owners67.22%
Inst Owner ChangeN/A
Ins Owners12.42%
Ins Owner Change0%
Market Cap165.67M
Revenue(TTM)7.14M
Net Income(TTM)-20.60M
Analysts78.18
Price Target5.78 (64.67%)
Short Float %1.94%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-299.39%
Min EPS beat(2)-482.33%
Max EPS beat(2)-116.45%
EPS beat(4)1
Avg EPS beat(4)-207.17%
Min EPS beat(4)-482.33%
Max EPS beat(4)21.14%
EPS beat(8)3
Avg EPS beat(8)-125.79%
EPS beat(12)6
Avg EPS beat(12)-81.64%
EPS beat(16)9
Avg EPS beat(16)-59.12%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.93%
PT rev (3m)183.34%
EPS NQ rev (1m)51.92%
EPS NQ rev (3m)-600%
EPS NY rev (1m)2.38%
EPS NY rev (3m)7.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.19
P/FCF N/A
P/OCF N/A
P/B 1.22
P/tB 1.22
EV/EBITDA N/A
EPS(TTM)-1.73
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)-2.06
OCFYN/A
SpS0.15
BVpS2.89
TBVpS2.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.66%
ROE -15.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.36%
FCFM N/A
ROA(3y)-51.3%
ROA(5y)-51.29%
ROE(3y)-66.33%
ROE(5y)-63.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 698.73%
Cap/Sales 7.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.26
Quick Ratio 10.26
Altman-Z 2.18
F-Score4
WACC9.2%
ROIC/WACCN/A
Cap/Depr(3y)1302.01%
Cap/Depr(5y)845.3%
Cap/Sales(3y)10.13%
Cap/Sales(5y)7.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.25%
EPS Next Y24.89%
EPS Next 2Y12.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-72.5%
Revenue growth 3Y-22.28%
Revenue growth 5Y-13.79%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y-76.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.62%
OCF growth 3YN/A
OCF growth 5YN/A

WHITEHAWK THERAPEUTICS INC / WHWK Fundamental Analysis FAQ

What is the fundamental rating for WHWK stock?

ChartMill assigns a fundamental rating of 3 / 10 to WHWK.


What is the valuation status of WHITEHAWK THERAPEUTICS INC (WHWK) stock?

ChartMill assigns a valuation rating of 0 / 10 to WHITEHAWK THERAPEUTICS INC (WHWK). This can be considered as Overvalued.


Can you provide the profitability details for WHITEHAWK THERAPEUTICS INC?

WHITEHAWK THERAPEUTICS INC (WHWK) has a profitability rating of 3 / 10.


What is the financial health of WHITEHAWK THERAPEUTICS INC (WHWK) stock?

The financial health rating of WHITEHAWK THERAPEUTICS INC (WHWK) is 8 / 10.


How sustainable is the dividend of WHITEHAWK THERAPEUTICS INC (WHWK) stock?

The dividend rating of WHITEHAWK THERAPEUTICS INC (WHWK) is 0 / 10 and the dividend payout ratio is 0%.